BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25575811)

  • 1. Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.
    Wang J; Liu M; Chen L; Chan TH; Jiang L; Yuan YF; Guan XY
    Oncotarget; 2015 Jan; 6(3):1618-30. PubMed ID: 25575811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
    Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
    J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
    Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
    Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
    Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
    Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
    Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
    J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3.
    Zhang X; Bai Y; Huang L; Liu S; Mo Y; Cheng W; Wang G; Cao Z; Chen X; Cui H; Qi L; Ma L; Liu M; Guan XY; Ma NF
    Cell Death Dis; 2021 Oct; 12(10):950. PubMed ID: 34654797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
    Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
    Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
    Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
    Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
    Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
    Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma.
    Zhang S; Shu R; Yue M; Zhang S
    Med Sci Monit; 2016 Aug; 22():3025-34. PubMed ID: 27566731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
    Lu WJ; Chua MS; So SK
    Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.
    Dai Y; Liu L; Zeng T; Liang JZ; Song Y; Chen K; Li Y; Chen L; Zhu YH; Li J; Li Y; Xie D; Yuan YF; Guan XY
    Am J Pathol; 2018 Feb; 188(2):378-391. PubMed ID: 29174628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.